Quarterly report pursuant to Section 13 or 15(d)

Derivative Financial Instruments

v3.19.1
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2018
Investments, All Other Investments [Abstract]  
Derivative Financial Instruments

11. DERIVATIVE FINANCIAL INSTRUMENTS

 

On May 18, 2018, as an inducement to enter into an Amended and Restated Loan Agreement, the Company issued, among other instruments, warrants to acquire 320,000 shares of common stock with an exercise price of $0.10 per share in Canadian dollars (see note 8). The warrants are valued using the Black Scholes Option Pricing Model and the derivative is fair valued at the end of each reporting period. The Company assessed an initial derivative liability of $30,012. The Company recorded a loss for the period ended September 30, 2018 of $4,357 to adjust the liability to its fair value at the end of the reporting period of $34,369.